Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference85 articles.
1. Cancer statistics;Siegel;CA Cancer J. Clin,2018
2. Treatment of non-metastatic muscle-invasive bladder Cancer: aua/asco/astro/SUO guideline;Chang;J Urol,2017
3. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration;Eur Urol,2005
4. Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials;Leow;Eur Urol,2014
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma;Frontiers in Pharmacology;2024-03-20
2. The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway;Combinatorial Chemistry & High Throughput Screening;2023-11-27
3. Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer;Oncology and Therapy;2023-01-03
4. Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond;Expert Opinion on Pharmacotherapy;2022-11-29
5. Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma;Clinical Genitourinary Cancer;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3